Gigi Kwik Gronvall

Gigi Gronvall is a Senior Scholar at the Johns Hopkins Center for Health Security and an Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. Gronvall is the author of the book Synthetic Biology: Safety, Security, and Promise, published in fall 2016 (Health Security Press) and Preparing for Bioterrorism: The Alfred P. Sloan Foundation’s Leadership in Biosecurity. (2013).  She is a member of the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC), which provides recommendations to the NIH Director, and a member of the Threat Reduction Advisory Committee (TRAC), which provides the U.S. Secretary of Defense with independent advice about the risks posed by nuclear, biological, chemical, and conventional threats. Gronvall received a BS in biology from Indiana University, Bloomington, and a PhD from Johns Hopkins University for work on T-cell receptor/MHC I interactions. She was a postdoctoral fellow at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, Maryland. Gronvall is a Life Member of the Council on Foreign Relations.

Governance

Strengthening the Biological Weapons Convention's Contributions to Global Health Security

Countering Russian disinformation creates opportunities to enhance the BWC's role against dangerous pathogens

Governance

Disarming Russia's Bioweapons Disinformation

Protecting Ukraine's laboratory infrastructure is crucial to prevent a health crisis

Urbanization

Emergency Departments: A Site for Future COVID-19 Vaccinations

Given equity considerations, emergency departments should be used to expand vaccine distribution

Migration

Spread of COVID-19 Variants Adds to Urgency of Disease Control Efforts

Increasing evidence suggests new COVID-19 variants are more transmissible between people

Governance

Laboratory Diagnostics—Rarely Appreciated Until Something Goes Wrong

Problems with COVID-19 testing highlights need for strong U.S. labs to detect, control, and respond to emerging diseases